Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi: Cronos Group (CRON)

Minimal geopolitical risk makes the business dependent only on local laws, and by comparing EBITDA tracking on GURU.Markets, we see that the metric value is 25.71. Cronos Group Inc. (CRON) relies on support from Altria in the innovative vape segment, developing R&D potential to create high-quality medical products. This chart captures the real return from the company's core operations.

CRON Bathi operasional EBITDA Cronos Group Inc. (23.11.2025 - 10.11.2026)

Ringkesan rincian data analitis Cronos Group (CRON)

- rega pasar lan target rega analis:

Rega saham Cronos Corp|CRON - Bagan rega target

- indikator kapitalisasi bursa perusahaan:

Nilai pasar Cronos Group|CRON - Nilai Total Perusahaan

- informasi kapitalisasi buku:

Nilai Akuntansi saben Saham Cronos Group|CRON - Kapitalisasi Buku|Rasio Kapitalisasi marang Aset Bersih thecronosgroup.com|CRON - Aset Agregat Perusahaan

- data tingkat utang lan likuiditas finansial:

Rasio Kabeh Utang marang Dana Pribadi Cronos Group Inc.|CRON - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Cronos Group Inc|CRON - Utang perusahaan|Rasio utang marang nilai buku Cronos Group|CRON - Utang jangka dawa perusahaan|Utang jangka cendhak Cronos Group|Koefisien jangkoan perantara thecronosgroup.com

- data bathi lan kelipatan valuasi:

CRON - Penghasilan resik|Penghasilan resik sing dikarepake Cronos Group Inc.|CRON - Pangali P/E|Pangali forward rega marang bathi thecronosgroup.com|CRON - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Cronos Group|CRON - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan Cronos Group|CRON - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan thecronosgroup.com|CRON - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Cronos Group Inc.

Analisis kabeh metrik perusahaan:Cronos Corp - CRON

The sale of laboratory-grade medical cannabis generates the primary cash flow for Cronos Group Inc. (CRON). The algorithm aggregates actual receipts from core operations, excluding the impact of loans and taxes. This metric determines the business's real ability to scale and confirms the stability of the operating model. An analysis of extremes allows for the separation of systemic growth from random revenue spikes. Use EBITDA_Co monitoring to assess the fundamental value of the company.

Pesaing Cronos Group Inc. (CRON)